Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Risk prediction models for mortality in community-acquired pneumonia: a systematic review.

Kwok CS, Loke YK, Woo K, Myint PK.

Biomed Res Int. 2013;2013:504136. doi: 10.1155/2013/504136. Epub 2013 Oct 21.

2.

Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis.

Loke YK, Kwok CS, Niruban A, Myint PK.

Thorax. 2010 Oct;65(10):884-90. doi: 10.1136/thx.2009.134072. Epub 2010 Aug 20. Review.

PMID:
20729235
3.

External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia.

Nüllmann H, Pflug MA, Wesemann T, Heppner HJ, Pientka L, Thiem U.

BMC Infect Dis. 2014 Jan 22;14:39. doi: 10.1186/1471-2334-14-39.

4.

Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.

Marti C, Garin N, Grosgurin O, Poncet A, Combescure C, Carballo S, Perrier A.

Crit Care. 2012 Jul 27;16(4):R141. doi: 10.1186/cc11447. Review.

5.

Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.

Yang Y, Xu F, Shi LY, Diao R, Cheng YS, Chen XY, Jing JY, Wang XD, Shen HH.

Chin Med J (Engl). 2012 Feb;125(4):639-45.

PMID:
22490488
6.

Short-term mortality of adult inpatients with community-acquired pneumonia: external validation of a modified CURB-65 score.

Pflug MA, Tiutan T, Wesemann T, Nüllmann H, Heppner HJ, Pientka L, Thiem U.

Postgrad Med J. 2015 Feb;91(1072):77-82. doi: 10.1136/postgradmedj-2014-132802. Epub 2015 Jan 24.

PMID:
25618316
7.

Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.

España PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacaín R, Menendez R, Torres A.

J Infect. 2010 Feb;60(2):106-13. doi: 10.1016/j.jinf.2009.11.013. Epub 2009 Dec 2. Review.

PMID:
19961875
8.

Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia.

Dwyer R, Hedlund J, Darenberg J, Henriques-Normark B, Naucler P, Runesdotter S, Kalin M.

Scand J Infect Dis. 2011 Jul;43(6-7):448-55. doi: 10.3109/00365548.2011.562529. Epub 2011 Mar 3.

PMID:
21370939
9.
10.

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.

Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ.

Am J Med. 2005 Apr;118(4):384-92.

PMID:
15808136
11.

Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index.

Abisheganaden J, Ding YY, Chong WF, Heng BH, Lim TK.

Respirology. 2012 Aug;17(6):969-75. doi: 10.1111/j.1440-1843.2012.02183.x.

PMID:
22574694
12.

Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia.

Lee JH, Chung HJ, Kim K, Jo YH, Rhee JE, Kim YJ, Kang KW.

Am J Emerg Med. 2013 Jan;31(1):72-9. doi: 10.1016/j.ajem.2012.06.004. Epub 2012 Aug 3.

PMID:
22867824
13.

Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study.

Kolditz M, Höffken G, Martus P, Rohde G, Schütte H, Bals R, Suttorp N, Pletz MW; CAPNETZ study group..

BMC Infect Dis. 2012 Apr 13;12:90. doi: 10.1186/1471-2334-12-90.

14.

CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting.

Guo Q, Li HY, Zhou YP, Li M, Chen XK, Liu H, Peng HL, Yu HQ, Chen X, Liu N, Liang LH, Zhao QZ, Jiang M.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3281-6. doi: 10.1007/s10096-012-1693-8. Epub 2012 Jul 18.

PMID:
22806350
15.

Performances of prognostic scoring systems in patients with healthcare-associated pneumonia.

Jeong BH, Koh WJ, Yoo H, Um SW, Suh GY, Chung MP, Kim H, Kwon OJ, Jeon K.

Clin Infect Dis. 2013 Mar;56(5):625-32. doi: 10.1093/cid/cis970. Epub 2012 Nov 15.

PMID:
23155150
16.

CRB-65 predicts death from community-acquired pneumonia.

Bauer TT, Ewig S, Marre R, Suttorp N, Welte T; CAPNETZ Study Group..

J Intern Med. 2006 Jul;260(1):93-101.

17.

Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups.

Ewig S, Bauer T, Richter K, Szenscenyi J, Heller G, Strauss R, Welte T.

Eur Respir J. 2013 Apr;41(4):917-22. doi: 10.1183/09031936.00065212. Epub 2012 Aug 16.

18.

Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review.

Cavallazzi R, El-Kersh K, Abu-Atherah E, Singh S, Loke YK, Wiemken T, Ramirez J.

Respir Med. 2014 Nov;108(11):1569-80. Review.

19.

A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia.

Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV.

Thorax. 2006 May;61(5):419-24. Epub 2006 Jan 31.

20.

Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.

Arnold FW, Brock GN, Peyrani P, Rodríguez EL, Díaz AA, Rossi P, Ramirez JA; CAPO authors..

Respir Med. 2010 Nov;104(11):1736-43. doi: 10.1016/j.rmed.2010.05.022. Epub 2010 Jun 23.

Supplemental Content

Support Center